LIMNW
Financials
- Market Capitalization 4.8355 M
- Employee 1
- Founded N/A
- CEO N/A
- Website liminatuspharma.com
- Headquarter Delaware, United States
- FIGI BBG01HVYG111
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5285 |  GRFS Grifols, S.A. - American Depositary Shares | 7.73 USD | +0.13% | -4.45% | -2.15% | -20.14% | 0 USD | ||
| 7249 |  SCLXW Scilex Holding Company - Warrant | 0.1162 USD | -10.62% | -31.65% | -41.90% | -74.74% | 45.86 M USD | ||
| 7316 |  MDCXW Medicus Pharma Ltd. - Warrant | 0.3879 USD | 0.00% | 0.00% | -11.58% | -50.25% | 15.80 M USD | ||
| 7341 |  ERNAW Ernexa Therapeutics Inc. - Warrants | 0.0441 USD | -23.97% | -11.80% | -33.18% | -55.90% | 7.10 M USD |
Frequently asked questions about Liminatus Pharma, Inc. Class A Common Stock
What is the Liminatus Pharma, Inc. Class A Common Stock stock price today?
The current price of Liminatus Pharma, Inc. Class A Common Stock (LIMNW) is 0.0552. Over the past 24 hours, the stock has changed by -35.65%. Follow the LIMNW chart for real-time price dynamics.
What is the stock ticker of Liminatus Pharma, Inc. Class A Common Stock?
Liminatus Pharma, Inc. Class A Common Stock trades under the ticker LIMNW. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Liminatus Pharma, Inc. Class A Common Stock stock going up?
LIMNW has changed by +22.67% over the last week, -30.39% over the last month, and -74.18% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Liminatus Pharma, Inc. Class A Common Stock?
Liminatus Pharma, Inc. Class A Common Stock currently has a market capitalization of 4.84 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Liminatus Pharma, Inc. Class A Common Stock earnings last quarter?
Last quarter, Liminatus Pharma, Inc. Class A Common Stock reported earnings of -1.5 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Liminatus Pharma, Inc. Class A Common Stock net income for the last quarter?
Liminatus Pharma, Inc. Class A Common Stock reported net income of -1.41 M for the last quarter. The previous quarter showed -1.12 M, which means net income changed by -25.23%.
How many employees does Liminatus Pharma, Inc. Class A Common Stock have?
As of the latest available data, Liminatus Pharma, Inc. Class A Common Stock has 1 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Liminatus Pharma, Inc. Class A Common Stock stock?
You can buy Liminatus Pharma, Inc. Class A Common Stock (LIMNW) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Liminatus Pharma, Inc. Class A Common Stock stock?
Investing in Liminatus Pharma, Inc. Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LIMNW chart and related analysis on metatrader.com as part of your research.